Digitek Recall

Actavis Totowa LLC, a US manufacturer division of international generic drug maker Actavis Group has issued a nationwide recall for all lots of Digitek digoxin tablets (all strengths) for oral use.  The drugs are also distributed by Mylan Pharmaceuticals Inc. as Bertek and by UDL Laboratories as UDL.

The recall is due to a possible doubling of the approved level of active ingredient in the pills.  The double strength tablet can create a risk of digitalis toxicity (digoxin toxicity), particularly in patients with renal failure.  Effects of digitalis toxicity include nausea, vomiting, dizziness, low blood pressure, cardiac instability, and bradycardia.  In some cases, excessive digitalis intake can result in death.  Illnesses and injuries associated with the defective double strength pills have been reported.

Please visit the FDA Website for more information on this recall.

If you or a loved one has been affected by the Digitek recall, The Law Offices of Larry H. Parker wants to help.  Larry H. Parker and his team of pharmaceutical litigation attorneys form an experienced law firm with the ability and desire to successfully conclude your case.  Our attorneys have already helped over 100,000 clients.  To schedule an absolutely FREE, confidential, no obligation consultation, send us an email using our case submission form or call us at (800) 333-0000.  At Larry H. Parker, if we don't get you any money, we won't charge you a dime.  The Law Offices of Larry H. Parker represents clients in product liability cases throughout the United States, with offices in Long Beach, Los Angeles, Riverside, and Fresno, California and Phoenix and Tucson, Arizona.  Tough times call for tough lawyers.  At The Law Offices of Larry H. Parker, we'll fight for you!

Digitek® is a registered trademark of Actavis Totowa LLC.